CYOTSKELETAL OXIDATIVE MODIFICATIONS

细胞骨架氧化修饰

基本信息

  • 批准号:
    6372094
  • 负责人:
  • 金额:
    $ 26.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-08-15 至 2005-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (adapted from applicant's abstract): Alzheimer's Disease (AD) and Parkinson's Disease (PD) are debilitating neurodegenerative diseases that are characterized by the deposition of protein aggregates. These aggregates are correlated with the presence of oxidative stress markers, suggesting that either the formation of the aggregate or their toxicity is mediated by oxidative stress. Based on results obtained from immunocytochemical and biochemical studies in the previous grant period, the investigators hypothesize that oxidative insult is autocatalytic: Initially generated reactive oxygen species (ROS), generate lipoxidtaion and glycoxidation products. The adduction of at least two such prominent reactive aldehyde, 4-hydroxynonenal (HNE), and glyoxal, has been observed to create new binding sites for adventitious Fe and Cu ions, in a manner that the bound metals are capable of catalyzing reduction of either O2 or H2O2, generating additional ROS. This redox cycling generates a steady flux of ROS that further oxidizes the constituents of the aggregates as well as nearby lipids and sugars, thus amplifying the initial oxidative insult. The novel aspect of the proposed hypothesis is the recognition that lipoxidative and glycoxidative modification products enhance, either directly or indirectly, the ability of the protein aggregates to generate ROS through their binding of adventitious redox active metal ions. In order to carefully characterize the chemical nature of oxidative damage induced by adventitiously-bound metals, investigators will study the effect of metal ions and aldehydic modifies on the aggregation and oxidation of A-beta, paired helical filament-tau and alpha-synuclein. A comparison of these results to the patterns of oxidative damage generated on their preformed aggregates will reveal whether aggregation inhibits or promotes individual types of oxidation. In parallel the investigators will continue the studies of the chemical nature and time course of oxidative stress revealed by immunocytochemical studies of brain autopsy material. Antibodies of defined specificity will facilitate the identification of the spatio-temporal characteristics of oxidative stress while mass spectroscopic studies will be used to identify and quantify the chemical nature of the oxidative lesions detected. The unique strength of the proposal is the interplay between the immunocytochemical studies and the chemical and mass spectroscopic characterization of specific defects. The results should provide diagnostic markers and help establish an improved rationale for pharmaceutical intervention.
描述(改编自申请人摘要):阿尔茨海默病(AD)和

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vernon E. Anderson其他文献

Identification of a New Allelic Variant of the Acinetobacter baumannii Cephalosporinase , ADC-7-Lactamase : Defining a Unique Family of Class C Enzymes ‡
鲍曼不动杆菌头孢菌素酶 ADC-7-内酰胺酶新等位基因变体的鉴定:定义独特的 C 类酶家族 ‡
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    K. Hujer;N. Hamza;A. Hujer;Federico Perez;M. S. Helfand;C. Bethel;J. M. Thomson;Vernon E. Anderson;Miriam Barlow;Louis B. Rice;F. Tenover;R. Bonomo
  • 通讯作者:
    R. Bonomo
Tazobactam Inactivation of SHV-1 and the Inhibitor-resistant Ser<sup>130</sup> → Gly SHV-1 β-Lactamase: INSIGHTS INTO THE MECHANISM OF INHIBITION
  • DOI:
    10.1074/jbc.m311669200
  • 发表时间:
    2004-05-07
  • 期刊:
  • 影响因子:
  • 作者:
    Doritza Pagan-Rodriguez;Xiang Zhou;Reiko Simmons;Christopher R. Bethel;Andrea M. Hujer;Marion S. Helfand;Zhaoyan Jin;Baochuan Guo;Vernon E. Anderson;Lily M. Ng;Robert A. Bonomo
  • 通讯作者:
    Robert A. Bonomo

Vernon E. Anderson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vernon E. Anderson', 18)}}的其他基金

MITOCHONDRIAL HYPOXIA: PRODUCTION AND REACTION OF ROS
线粒体缺氧:ROS 的产生和反应
  • 批准号:
    6783211
  • 财政年份:
    2004
  • 资助金额:
    $ 26.78万
  • 项目类别:
Gel Permeation Chromatograph/Laser Light Scattering
凝胶渗透色谱/激光光散射
  • 批准号:
    6582604
  • 财政年份:
    2003
  • 资助金额:
    $ 26.78万
  • 项目类别:
Hydroxyl radical mapping of protein interfaces
蛋白质界面的羟基自由基图谱
  • 批准号:
    6832739
  • 财政年份:
    2001
  • 资助金额:
    $ 26.78万
  • 项目类别:
Hydroxyl radical mapping of protein interfaces
蛋白质界面的羟基自由基图谱
  • 批准号:
    6927150
  • 财政年份:
    2001
  • 资助金额:
    $ 26.78万
  • 项目类别:
Hydroxyl radical mapping of protein interfaces
蛋白质界面的羟基自由基图谱
  • 批准号:
    6408335
  • 财政年份:
    2001
  • 资助金额:
    $ 26.78万
  • 项目类别:
Hydroxyl radical mapping of protein interfaces
蛋白质界面的羟基自由基图谱
  • 批准号:
    7068210
  • 财政年份:
    2001
  • 资助金额:
    $ 26.78万
  • 项目类别:
ISCHEMIC/REPERFUSION DAMAGE TO THE RIESKE IRON PROTEIN
RIESKE 铁蛋白的缺血/再灌注损伤
  • 批准号:
    6359553
  • 财政年份:
    2000
  • 资助金额:
    $ 26.78万
  • 项目类别:
ISCHEMIC/REPERFUSION DAMAGE TO THE RIESKE IRON PROTEIN
RIESKE 铁蛋白的缺血/再灌注损伤
  • 批准号:
    6098817
  • 财政年份:
    1999
  • 资助金额:
    $ 26.78万
  • 项目类别:
ISCHEMIC/REPERFUSION DAMAGE TO THE RIESKE IRON PROTEIN
RIESKE 铁蛋白的缺血/再灌注损伤
  • 批准号:
    6218773
  • 财政年份:
    1999
  • 资助金额:
    $ 26.78万
  • 项目类别:
ISCHEMIC/REPERFUSION DAMAGE TO THE RIESKE IRON PROTEIN
RIESKE 铁蛋白的缺血/再灌注损伤
  • 批准号:
    6267775
  • 财政年份:
    1998
  • 资助金额:
    $ 26.78万
  • 项目类别:

相似海外基金

Apolipoprotein B and associated proteins in the etiology of Alzheimer's disease: A Tau-specific association with Alzheimer pathophysiology.
阿尔茨海默病病因中的载脂蛋白 B 和相关蛋白:与阿尔茨海默病病理生理学的 Tau 特异性关联。
  • 批准号:
    444020
  • 财政年份:
    2021
  • 资助金额:
    $ 26.78万
  • 项目类别:
    Operating Grants
A whole-animal small molecule screen to identify and characterize modifiers of Apolipoprotein B
用于识别和表征载脂蛋白 B 修饰物的全动物小分子筛选
  • 批准号:
    10261421
  • 财政年份:
    2020
  • 资助金额:
    $ 26.78万
  • 项目类别:
A whole-animal small molecule screen to identify and characterize modifiers of Apolipoprotein B
用于识别和表征载脂蛋白 B 修饰物的全动物小分子筛选
  • 批准号:
    10460567
  • 财政年份:
    2020
  • 资助金额:
    $ 26.78万
  • 项目类别:
In vivo HTS assay for novel modulators of Apolipoprotein B
载脂蛋白 B 新型调节剂的体内 HTS 测定
  • 批准号:
    10398022
  • 财政年份:
    2018
  • 资助金额:
    $ 26.78万
  • 项目类别:
In vivo HTS assay for novel modulators of Apolipoprotein B
载脂蛋白 B 新型调节剂的体内 HTS 测定
  • 批准号:
    10502731
  • 财政年份:
    2018
  • 资助金额:
    $ 26.78万
  • 项目类别:
In vivo HTS assay for novel modulators of Apolipoprotein B
载脂蛋白 B 新型调节剂的体内 HTS 测定
  • 批准号:
    9976330
  • 财政年份:
    2018
  • 资助金额:
    $ 26.78万
  • 项目类别:
In vivo HTS assay for novel modulators of Apolipoprotein B
载脂蛋白 B 新型调节剂的体内 HTS 测定
  • 批准号:
    9788423
  • 财政年份:
    2018
  • 资助金额:
    $ 26.78万
  • 项目类别:
The Role of Sortilin in the Regulation of Apolipoprotein B Secretion from the liver and heart
分拣蛋白在调节肝脏和心脏载脂蛋白 B 分泌中的作用
  • 批准号:
    9329077
  • 财政年份:
    2017
  • 资助金额:
    $ 26.78万
  • 项目类别:
Translational Control of Apolipoprotein B mRNA
载脂蛋白 B mRNA 的翻译控制
  • 批准号:
    41858-2012
  • 财政年份:
    2016
  • 资助金额:
    $ 26.78万
  • 项目类别:
    Discovery Grants Program - Individual
Translational Control of Apolipoprotein B mRNA
载脂蛋白 B mRNA 的翻译控制
  • 批准号:
    41858-2012
  • 财政年份:
    2015
  • 资助金额:
    $ 26.78万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了